loadpatents
name:-0.051102161407471
name:-0.018886089324951
name:-0.00864577293396
PIKE; Kurt Gordon Patent Filings

PIKE; Kurt Gordon

Patent Applications and Registrations

Patent applications and USPTO patent grants for PIKE; Kurt Gordon.The latest application filed is for "fused tricyclic compounds useful as anticancer agents".

Company Profile
8.17.42
  • PIKE; Kurt Gordon - Cambridge GB
  • PIKE; Kurt Gordon - Little Chesterford GB
  • Pike; Kurt Gordon - Cheshire GB
  • Pike; Kurt Gordon - Macclesfield GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fused Tricyclic Compounds Useful As Anticancer Agents
App 20220204527 - KETTLE; Jason Grant ;   et al.
2022-06-30
Deuterated Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20210347775 - PIKE; Kurt Gordon ;   et al.
2021-11-11
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20210147416 - Barlaam; Bernard Christophe ;   et al.
2021-05-20
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 10,882,858 - Barlaam , et al. January 5, 2
2021-01-05
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20200102302 - Barlaam; Bernard Christophe ;   et al.
2020-04-02
Deuterated Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20200087300 - PIKE; Kurt Gordon ;   et al.
2020-03-19
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 10,457,679 - Barlaam , et al. Oc
2019-10-29
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20190185468 - BARLAAM; Bernard Christophe ;   et al.
2019-06-20
N-Oxide Compound and Its Use in Treating Cancer
App 20190119270 - BARLAAM; Bernard Christophe ;   et al.
2019-04-25
Cinnolin-4-amine Compounds And Their Use In Treating Cancer
App 20190099421 - PIKE; Kurt Gordon ;   et al.
2019-04-04
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 10,189,834 - Barlaam , et al. Ja
2019-01-29
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20180318287 - PIKE; Kurt Gordon ;   et al.
2018-11-08
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20180280377 - PIKE; Kurt Gordon ;   et al.
2018-10-04
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20180141943 - Barlaam; Bernard Christophe ;   et al.
2018-05-24
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20180134699 - BARLAAM; Bernard Christophe ;   et al.
2018-05-17
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 9,856,255 - Barlaam , et al. January 2, 2
2018-01-02
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer
Grant 9,822,111 - Barlaam , et al. November 21, 2
2017-11-21
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20170081325 - Barlaam; Bernard Christophe ;   et al.
2017-03-23
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20160368920 - BARLAAM; Bernard Christophe ;   et al.
2016-12-22
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating Cancer
Grant 9,428,503 - Barlaam , et al. August 30, 2
2016-08-30
Imidazo[4,5-c]quinolin-2-one Compounds and Their Use in Treating Cancer
App 20150336952 - BARLAAM; Bernard Christophe ;   et al.
2015-11-26
Morpholino pyrimidine derivatives used in diseases linked to mTOR kinase and/or PI3K
Grant 8,138,183 - Pike March 20, 2
2012-03-20
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
Grant 7,977,328 - McKerrecher , et al. July 12, 2
2011-07-12
Heteroarylbenzamide derivatives for use in the treatment of diabetes
Grant 7,964,725 - Martin , et al. June 21, 2
2011-06-21
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
Grant 7,943,607 - McKerrecher , et al. May 17, 2
2011-05-17
2-phenyl Substituted Imidazol [4,5b] Pyridine/pyrazine And Purine Derivatives As Glucokinase Modulators
App 20110059941 - Caulkett; Peter William Rodney ;   et al.
2011-03-10
Chemical compounds
Grant 7,902,200 - Campbell , et al. March 8, 2
2011-03-08
2 -heterocyclyloxybenzoyl Amino Heterocyclyl Compounds As Modulators Of Glucokinase For The Treatment Of Type 2 Diabetes
App 20110053910 - McKerrecher; Darren ;   et al.
2011-03-03
Morpholino Pyrimidine Derivatives And Their Use In Therapy
App 20110034454 - Dishington; Allan Paul ;   et al.
2011-02-10
Benzamide Derivatives And Their Use As Glucokinase Activating Agents
App 20110034432 - JOHNSTONE; Craig ;   et al.
2011-02-10
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
Grant 7,842,694 - McKerrecher , et al. November 30, 2
2010-11-30
Morpholino Pyrimidine Derivatives Used In Diseases Linked To Mtor Kinase And/or Pi3k
App 20100249131 - Pike; Kurt Gordon
2010-09-30
Trisubstituted Pyrimidine Derivatives For The Treatment Of Proliferative Diseases
App 20100227858 - Finlay; Maurice Raymond, Verschoyle ;   et al.
2010-09-09
Heteroaryl Benzamide Derivatives
App 20100173825 - Martin; Nathaniel George ;   et al.
2010-07-08
Compounds-943
Grant 7,750,003 - Finlay , et al. July 6, 2
2010-07-06
Heteroaryl benzamide derivatives as GLK activators
Grant 7,745,475 - Johnstone , et al. June 29, 2
2010-06-29
Heteroaryl benzamide derivatives
Grant 7,671,060 - Martin , et al. March 2, 2
2010-03-02
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
Grant 7,642,263 - McKerrecher , et al. January 5, 2
2010-01-05
Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
Grant 7,642,259 - McKerrecher , et al. January 5, 2
2010-01-05
Heteroaryl Benzamide Derivatives For Use As Glk Activators In The Treatment Of Diabetes
App 20090264336 - MCKERRECHER; Darren ;   et al.
2009-10-22
Heteroaryl Benzamide Derivatives for Use as GLK Activators in the Treatment of Diabetes
App 20090253676 - Johnstone; Craig ;   et al.
2009-10-08
Heteroaryl Benzamide Derivatives For Use As Glk Activators In The Treatment Of Diabetes
App 20090118159 - McKerrecher; Darren ;   et al.
2009-05-07
Heteroaryl Benzamide Derivatives For Use As Glk Activators In The Treatment Of Diabetes
App 20090111790 - MCKERRECHER; Darren ;   et al.
2009-04-30
Heterobicyclic Compounds As Glucokinase Activators
App 20090105263 - Caulkett; Peter William Rodney ;   et al.
2009-04-23
Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
App 20090105214 - McKerrecher; Darren ;   et al.
2009-04-23
Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (glk) activators
App 20090062351 - Caulkett; Peter William Rodney ;   et al.
2009-03-05
Heteroaryl Benzamide Derivatives For Use As Glk Activators In The Treatment Of Diabetes
App 20090029905 - MCKERRECHER; Darren ;   et al.
2009-01-29
Chemical compounds
App 20090018157 - Johnstone; Craig ;   et al.
2009-01-15
Compounds - 945
App 20090018134 - PIKE; Kurt Gordon ;   et al.
2009-01-15
Chemical Compounds
App 20080318968 - Martin; Nathaniel George ;   et al.
2008-12-25
Compounds
App 20080312207 - Johnstone; Craig ;   et al.
2008-12-18
Phenoxy Benzamide Compounds with Utility in the Treatment of Type 2 Diabetes and Obesity
App 20080280874 - Johnstone; Craig ;   et al.
2008-11-13
Benzamide Derivatives and Their Use as Glucokinase Activating Agents
App 20080280872 - Johnstone; Craig ;   et al.
2008-11-13
Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
App 20080234273 - McKerrecher; Darren ;   et al.
2008-09-25
Transcutaneous immunostimulation
App 20080171743 - Finlay; Maurice Raymond Verschoyle ;   et al.
2008-07-17
Chemical Compounds
App 20080171734 - Campbell; Leonie ;   et al.
2008-07-17
Heteroaryl Benzamide Derivatives for Use as Glk Activators in the Treatment of Diabetes
App 20080015203 - Johnstone; Craig ;   et al.
2008-01-17
Benzamide Derivatives That Act Upon The Glucokinase Enzyme
App 20070287693 - Johnstone; Craig ;   et al.
2007-12-13
Benzoyl Amino Pyridyl Carboxylic Acid Derivatives Useful as Glucokinase (Glk) Activators
App 20070255062 - Johnstone; Craig ;   et al.
2007-11-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed